Making Strides in Breast Cancer with Vanderbilt University and Team Martina

During Breast Cancer Awareness Month, it's a special honor to feature the heart-work of Vanderbilt-Ingram Cancer Center and Team Martina. Triple negative breast cancer is one of the most aggressive types and doesn't respond well to known treatment protocols. Specifically-targeted research is urgently needed, and Vanderbilt-Ingram Cancer Center is dedicating the time, talent, and team to do it.

We'll revisit with Sheila Jones of Team Martina to hear exciting updates on the Martina McBride Breast Cancer Research Grant. The grant helped make strides in triple negative research over the last year, honoring of a teammate who died of the disease. Now, there's more potential for the grant with a "Coffee for a Cure" campaign and it's gone nationwide. The community initiative shows the impact when people come together for good.

Dr. Vandana Abramson will join us, too. She's a breast cancer physician and researcher at Vanderbilt University and the Vanderbilt-Ingram Cancer Center. After receiving her B.A. in English and Molecular & Cell Biology at the University of California, Berkeley, she went to medical school at the University of Chicago. Dr. Abramson completed her Internal Medicine Residency at Harvard University's Brigham and Women's Hospital.  She then went on to complete a fellowship in Hematology/Oncology at the University of Pennsylvania in Philadelphia, PA.  She also obtained a Master's degree in Translational Research.

Dr. Abramson research focuses on early stage clinical trials of novel treatments for all types of breast cancers, and she has received grants to study triple negative breast cancer.  She has received awards for her clinical and research work and is currently leading clinical trials in breast cancer, both at Vanderbilt and nationally.  Don't miss this extraordinary hour of updates!